PPT-Measles Measles What is measles?

How do you catch measles What is the incubation period for measles Can animals catch measles How can measles be prevented Infectious viral illness AirborneDroplet 10 days No Vaccination MMR vaccine. What causes measles? Measles disease is caused by a virus. his virus infects humans, causing measles diseasein anyone who is not immunized or who has not previously Measles Disease: Q & A I have bee Immunisation. Activities . Quality . 5. th. African Measles and Rubella TAG Meeting. Nairobi, Kenya, 2-3 June 2015. Outline . Targets for measles elimination in AFR. M . & MR SIAs achievement . . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. Panel 01502. Vicki Stambos. The 13. th. Global Measles and Rubella Laboratory Network Meeting, Geneva, Switzerland, 29. th. June to 1. st. July 2015. Vicki Stambos. Accelerating Progress Towards Measles and Rubella Control and Elimination Meeting. WHO Western Pacific Region. UNICEF East Asia and Pacific Region. 1. 21 June 2016. Geneva, Switzerland. Regional Measles and Rubella Goals. 2003. : Measles elimination to be used to strengthen routine immunization . assessment. Dr. Satish Gupta. Measles Rubella Initiative Meeting. 18-19 September 2012. Washington DC. The India Measles SIA . India Technical advisory group on immunizations endorses the following. Delivery of second dose of measles vaccine should be via SIA in states with MCV1 coverage <80% . Accelerating progress towards measles and rubella elimination. Geneva, Switzerland 21-23 June 2016 . Jenny Rota, WHO consultant. Goal is to update information to reflect current responsibilities of the network, provide best practices, resources and guidelines. ASSO. PROF.PEDIATRICS. ICH,GOVT MEDICAL COLLEGE KOTTAYAM. LEARNING OBJECTIVES. To list essential features of clinical measles. To list 2 complications of measles. To write a treatment protocol for measles. Overview . of Supply through UNICEF. 2017 Measles & Rubella Initiative Partners’ Meeting . 7-. 8. September 2017. MCV Demand through UNICEF 1/2. UNICEF . procures MCV on behalf . of . on . average . . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. Assessments. June 21-23, 2016, Geneva, Switzerland. . Accelerating Progress towards Measles/Rubella Control and Elimination Goals . James L. . Goodson. Global . Immunization Division. Centers. for Disease Control and Prevention . Donald McLaren, MD.   . Seventh International Symposium in Continuing Nursing Education/March 2014. Goals of talk. To highlight measles as a still very important major cause of under 5 mortality in the developing world and discuss diagnosis, complications and treatment. D. Amani Elgadal. D. efinition. Measles is a highly contagious viral infection. It is exanthematous disease with fever, cough, coryza (rhinitis) and conjunctivitis. . Measles. Etiology/agent factor . paramyxovirus.. morbillivirus. it is spherical in appearance ,measuring about 100~150nm in diameter . It has an outer envelope composed of M-protein, H-protein, F-protein, and internal core is RNA..